CNR -- National Research Council of Italy, Via Real Collegio, N. 30 (Collegio Carlo Alberto), 10024, Moncalieri (TO), Italy.
Environ Res. 2021 Jun;197:111099. doi: 10.1016/j.envres.2021.111099. Epub 2021 Apr 2.
The goal of this study is a comparative analysis of the first and second wave of the Coronavirus disease 2019 (COVID-19) to assess the impact on health of people for designing effective policy responses to constrain negative effects of future pandemic waves of COVID-19 and similar infectious diseases in society. The research here focuses on a case study of Italy, one of the first countries to experience a rapid increase in numbers of COVID-19 related infected individuals and deaths. Statistical analyses, based on daily data from February 2020 to February 2021, suggest that the first wave of COVID-19 pandemic in Italy had a high negative impact on health of people over February-May 2020 period; after that, negative effects declined from June 2020 onwards. Second wave of COVID-19 pandemic from August 2020 to February 2021 had a growing incidence of confirmed cases also associated with variants of coronavirus, whereas admissions to Intensive Care Units and total deaths had lower levels compared to first wave of COVID-19. Lessons learned of this comparative analysis between first and second wave of the COVID-19 pandemic in Italy can be generalized in similar geo-economic areas to support effective policy responses of crisis management to constrain the negative impact on health of people of recurring waves of COVID-19 pandemic and similar infectious diseases in future.
本研究的目的是对 2019 年冠状病毒病(COVID-19)的第一波和第二波进行比较分析,以评估其对人群健康的影响,从而为设计有效的政策应对措施提供依据,以限制未来 COVID-19 大流行波和类似传染病对社会的负面影响。本研究以意大利为案例研究,意大利是最早经历 COVID-19 相关感染人数和死亡人数迅速增加的国家之一。基于 2020 年 2 月至 2021 年 2 月的每日数据进行的统计分析表明,意大利 COVID-19 大流行的第一波对 2020 年 2 月至 5 月期间人群的健康产生了高度负面影响;此后,从 2020 年 6 月开始,负面影响逐渐下降。2020 年 8 月至 2021 年 2 月的 COVID-19 大流行第二波,确诊病例不断增加,同时也与冠状病毒变异株有关,而重症监护病房的入院人数和总死亡人数与 COVID-19 第一波相比则较低。从意大利 COVID-19 大流行的第一波和第二波之间的比较分析中得出的经验教训可以推广到类似的地缘经济地区,以支持有效的危机管理政策应对措施,限制未来 COVID-19 大流行波和类似传染病对人群健康的负面影响。